These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17824172)

  • 1. Estradiol action in atherosclerosis and reendothelialization.
    Arnal JF; Laurell H; Lenfant F; Douin-Echinard V; Brouchet L; Gourdy P
    Ernst Schering Found Symp Proc; 2006; (1):69-86. PubMed ID: 17824172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the oestrogen action in experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Brouchet L; Tremollières F; Laurell H; Lenfant F; Gadeau AP; Guery JC; Gourdy P
    Fundam Clin Pharmacol; 2006 Dec; 20(6):539-48. PubMed ID: 17109647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Tremollières F; Terrisse AD; Sié P; Payrastre B; Guery JC; Bayard F; Gourdy P
    Arch Mal Coeur Vaiss; 2007; 100(6-7):554-62. PubMed ID: 17893638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of experimental models to understand the vascular effects of estrogens].
    Arnal JF; Gourdy P; Garmy-Susini B; Delmas E; Bayard F
    Med Sci (Paris); 2003 Dec; 19(12):1226-32. PubMed ID: 14691747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology.
    Arnal JF; Laurell H; Fontaine C; Billon A; Calippe B; Lenfant F; Gourdy P
    Climacteric; 2009; 12 Suppl 1():12-7. PubMed ID: 19811234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens in vascular biology and disease: where do we stand today?
    Arnal JF; Scarabin PY; Trémollières F; Laurell H; Gourdy P
    Curr Opin Lipidol; 2007 Oct; 18(5):554-60. PubMed ID: 17885427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of inflammatory cytokines in the effect of estradiol on atheroma.
    Gourdy P; Calippe B; Laurell H; Trémollières F; Douin-Echinard V; Lenfant F; Bayard F; Guery JC; Arnal JF
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):396-401. PubMed ID: 18307728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing.
    Billon-Galés A; Krust A; Fontaine C; Abot A; Flouriot G; Toutain C; Berges H; Gadeau AP; Lenfant F; Gourdy P; Chambon P; Arnal JF
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13311-6. PubMed ID: 21788522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice.
    Billon-Galés A; Fontaine C; Douin-Echinard V; Delpy L; Berges H; Calippe B; Lenfant F; Laurell H; Guéry JC; Gourdy P; Arnal JF
    Circulation; 2009 Dec; 120(25):2567-76. PubMed ID: 19996016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol.
    Billon-Galés A; Fontaine C; Filipe C; Douin-Echinard V; Fouque MJ; Flouriot G; Gourdy P; Lenfant F; Laurell H; Krust A; Chambon P; Arnal JF
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2053-8. PubMed ID: 19188600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen elicits atheroprotection through estrogen receptor α AF-1 but does not accelerate reendothelialization.
    Fontaine C; Abot A; Billon-Galés A; Flouriot G; Bergès H; Grunenwald E; Vinel A; Valera MC; Gourdy P; Arnal JF
    Am J Pathol; 2013 Jul; 183(1):304-12. PubMed ID: 23669343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and atherosclerosis.
    Arnal JF; Gourdy P; Elhage R; Garmy-Susini B; Delmas E; Brouchet L; Castano C; Barreira Y; Couloumiers JC; Prats H; Prats AC; Bayard F
    Eur J Endocrinol; 2004 Feb; 150(2):113-7. PubMed ID: 14763907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogens and the arterial wall].
    Arnal JF; Elhage R; Brouchet L; Rami J; Maret A; Bayard F
    Ann Endocrinol (Paris); 2000 Feb; 61(1):80-4. PubMed ID: 10790597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization.
    Toutain CE; Filipe C; Billon A; Fontaine C; Brouchet L; Guéry JC; Gourdy P; Arnal JF; Lenfant F
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1543-50. PubMed ID: 19608969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators.
    Kublickiene K; Svedas E; Landgren BM; Crisby M; Nahar N; Nisell H; Poston L
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6113-22. PubMed ID: 16131583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.
    Smirnova NF; Fontaine C; Buscato M; Lupieri A; Vinel A; Valera MC; Guillaume M; Malet N; Foidart JM; Raymond-Letron I; Lenfant F; Gourdy P; Katzenellenbogen BS; Katzenellenbogen JA; Laffargue M; Arnal JF
    Circ Res; 2015 Oct; 117(9):770-8. PubMed ID: 26316608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta.
    Brouchet L; Krust A; Dupont S; Chambon P; Bayard F; Arnal JF
    Circulation; 2001 Jan; 103(3):423-8. PubMed ID: 11157695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?
    Lenfant F; Trémollières F; Gourdy P; Arnal JF
    Maturitas; 2011 Feb; 68(2):165-73. PubMed ID: 21167666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-atherogenic effects of 17β-estradiol.
    Resanovic I; Rizzo M; Zafirovic S; Bjelogrlic P; Perovic M; Savic K; Patti AM; Isenovic RE
    Horm Metab Res; 2013 Sep; 45(10):701-8. PubMed ID: 23681753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.